Miami Neuroscience Institute Stroke Update

This online course offers state-of-the-art, evidence-based practices for clinicians and healthcare professionals who treat and care stroke patients. The expert faculty will engage participants through complex cases, novel treatment strategies and lively panel discussions.

This course includes topics presented at the 11th annual Miami Neuroscience Symposium.

  • PRES and Reversible Cerebral Vasoconstriction Syndrome Neuroimaging Update
  • Management of Tandem Occlusion in Acute Ischemic Stroke
  • Neuroprotection in Acute Ischemic Stroke
  • Minimally Invasive Surgery for Management of Intracerebral Hemorrhage

Commercial Supporter

Baptist Health gratefully acknowledges the educational grants provided by Chiesi, Cerenovus, MicroVention, and Medtronic. 

 

Target Audience

Neurologists, Neurosurgeons, Neuroradiologists, Diagnostic Radiologists, Critical Care Physicians, Neurointensivists, Emergency Medicine Physicians, Internal Medicine Physicians, Interventional Neuroradiologists, Family Physicians, General Internists, Hospitalists, Advanced Practice Nurse Practitioners, Registered Nurses, Physician Assistants, Pharmacists, Pharmacy Technicians, Clinical Neurophysiology Technicians, Rehabilitation and Pain Management Specialists, as well as other specialists interested in the field of neuroscience.

Learning Objectives

  • Recognize, diagnose and manage inflammatory and non-inflammatory intracranial arteriopathies.
  • Select the best treatment strategy for patients with acute ischemic stroke and tandem occlusions.
  • Describe the benefit of minimally invasive surgery for acute intracranial hemorrhage.
  • Select patients who may benefit from minimally invasive surgery for acute intracranial hemorrhage.
Additional information
Bibliography: 
  • Mandell, D. M., Mossa-Basha, M., Qiao, Y., Hess, C. P., Hui, F., Matouk, C., ... & Mikulis, D. J. (2017). Intracranial vessel wall MRI: principles and expert consensus recommendations of the American Society of Neuroradiology. American Journal of Neuroradiology, 38(2), 218-229.
  • Zeiler, S. R., Qiao, Y., Pardo, C. A., Lim, M., & Wasserman, B. A. (2018). Vessel wall MRI for targeting biopsies of intracranial vasculitis. American Journal of Neuroradiology, 39(11), 2034-2036.
  • Marko, M., Cimflova, P., Poppe, A. Y., Kashani, N., Singh, N., Ospel, J., ... & Almekhlafi, M. A. (2022). Management and outcome of patients with acute ischemic stroke and tandem carotid occlusion in the ESCAPE-NA1 trial. Journal of NeuroInterventional Surgery, 14(5), 429-433.
  • Zevallos, C. B., Farooqui, M., Quispe‐Orozco, D., Mendez‐Ruiz, A., Dajles, A., Garg, A., ... & Ortega‐Gutierrez, S. (2022). Acute carotid artery stenting versus balloon angioplasty for tandem occlusions: a systematic review and meta‐analysis. Journal of the American Heart Association, 11(2), e022335.
  • Hill, M. D., Goyal, M., Menon, B. K., Nogueira, R. G., McTaggart, R. A., Demchuk, A. M., ... & O'Kelly, C. (2020). Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial. The Lancet, 395(10227), 878-887.
  • Greenberg, S. M., Ziai, W. C., Cordonnier, C., Dowlatshahi, D., Francis, B., Goldstein, J. N., ... & American Heart Association/American Stroke Association. (2022). 2022 Guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American Heart Association/American Stroke Association. Stroke, 53(7), e282-e361.
  • Matsoukas, S., Chennareddy, S., Kalagara, R., Scaggiante, J., Smith, C. J., Bazil, M. J., ... & Kellner, C. P. (2022). Pilot deployment of viz–intracranial hemorrhage for intracranial hemorrhage detection: real-world performance in a stroke code cohort. Stroke, 53(9), e418-e419.
Course Summary
Available credit: 
  • 2.00 ABS MOC II
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 General certificate of attendance
  • 2.00 Nurse Practitioners
  • 2.00 Florida Board of Nursing
  • 2.00 Florida Board of Pharmacy
Course opens: 
03/01/2024
Course expires: 
02/28/2027

Guilherme Dabus, M.D.    
Co-director, Interventional Neuroradiology
Baptist Health Miami Neuroscience Institute
Medical Director, Fellowship Program in Interventional Neuroradiology and Endovascular Neurosurgery 
Baptist Health Miami Cardiac & Vascular Institute and Baptist Health Miami Neuroscience Institute 
Clinical Professor, Department of Neuroscience
Florida International University Herbert Wertheim College of Medicine 
Miami, Florida    

Christopher P. Kellner, M.D.
Director, Intracerebral Hemorrhage Program
Principal Investigator, Cerebrovascular Translational Laboratory
Assistant Professor, Neurosurgery
Icahn School of Medicine at Mount Sinai
New York, New York

Italo Linfante, M.D., FAHA  
Director, Interventional Neuroradiology 
Baptist Health Miami Neuroscience Institute 
Clinical Professor of Radiology and Neuroscience 
Florida International University Herbert Wertheim College of Medicine
Miami, Florida 

Charif Sidani, M.D.
Neuroradiology Specialist
Baptist Health Quality Network
Miami, Florida

Robert Wicks, M.D.   
Co-director, Cerebrovascular Surgery
Director, Neurosurgery Anatomy Laboratory
Baptist Health Miami Neuroscience Institute
Miami, Florida

The following speakers have indicated that they do not have any relevant relationships with ineligible companies* to disclose.
Christopher P. Kellner, M.D.
Charif Sidani, M.D.
Robert Wicks, M.D.

The following symposium directors, planners and reviewers have indicated that they do not have any relevant relationships with ineligible companies* to disclose.
Starlie Belnap, Ph.D.
Nina Cruz, MSN, APRN
Karel Fuentes, M.D.
Jamelah Morton, APRN
Regine Narchet, R.N.
Vitaly Siomin, M.D.
Justin Sporrer, M.D.
Ronald Tolchin, D.O.

Kevin Abrams, M.D., is a consultant and a member of the speakers’ bureau for Viz.AI, and a shareholder for Viz.AI and Cleerly.  

Guilherme Dabus, M.D., speaker and conference director for this educational activity, is a consultant for Cerenovus, InNeuroCo, Medtronic, Microvention, Phenox, Penumbra, Route92, Stryker and Viz.Ai; a member of the speakers’ bureau for Cerenovus, InNeuroCo, Medtronic, Microvention, Penumbra, Phenox, Route92, Stryker and Viz.Ai; a stockholder in Cleerly, Hyperion, InNeuroCo, Prometheus Laboratories, RIST, Synchron, Three Rivers Medical, GHIF and Pireaus; receives research support from SUMMIT MAX; and is a committee member for CREST-2 Interventional Management.

Felipe De Los Rios La Rosa, M.D., is on the speakers’ bureau for AstraZeneca, Andexanet alfa and Brilinta.

Italo Linfante, M.D., speaker and conference director of this educational activity, is a consultant for QApel, Cerenovus, Stryker, Medtronic, Penumbra and Prolong Pharmaceuticals. 

Michael McDermott, M.D., is a consultant for Deinde Medical, Stryker, Insightec, ZAP Surgical and Light Helmets. 

Diego Torres-Russotto, M.D., is a consultant for AbbVie, Acorda, Ipsen, Neurocrine, Revance, Sunovion and Teva; is on the speakers’ bureau for AbbVie, Acorda, Ipsen, Neurocrine and Teva; and receives grant support from Ipsen, Merz and Revance.

All of the relevant financial relationships listed for these individuals have been mitigated.

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships with ineligible companies* to disclose. 

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. 

Disclosure Policy and Disclaimer

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
              
Baptist Health South Florida designates this enduring material for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.



American Board of Surgery - Accredited CME - General Surgery

Successful completion of this CME activity enables the learner to earn credit toward the CME requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit. 

Your participation information will be shared with specialty boards through the ACCME's PARS reporting system. Successful completion of a course examination is required. Submissions are recorded in approximately 48 hours. You will receive an email when your credits have been processed.

Available Credit

  • 2.00 ABS MOC II
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 General certificate of attendance
  • 2.00 Nurse Practitioners
  • 2.00 Florida Board of Nursing
  • 2.00 Florida Board of Pharmacy
Please login or register for a Baptist Health CME account to take this course.

Your participation information will be shared with specialty boards through the ACCME's PARS reporting system. Successful completion of a course examination is required. Submissions are recorded in approximately 48 hours. You will receive an email when your credits have been processed.

Required Hardware/Software

PC/Mac Users
PC/Mac Users

This site is supported on the most recent stable releases of the following browsers:

Click Here to Download Google Chrome
Google Chrome
Microsoft Edge
Microsoft Edge
Safari
Safari
Moxilla Firefox
Mozilla Firefox
Mobile Users
Mobile Users

This site is supported on the following mobile devices:

  • Apple iOS mobile devices running iOS 10 or later
  • Android mobile devices running Android 4.4 or later, with the latest release of Google Chrome or Mozilla Firefox
Technical Support
Technical Support

If you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.